Disaggregating the dementia monolith : An analysis of variation in Medicare costs and use by dementia subtype
© 2023 Alzheimer's Association. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA..
IMPORTANCE: With an aging population, it is necessary to systematically examine variation in costs and use of Medicare services by dementia subtype. We provide the first national estimates for dementia by subtype, and the respective Medicare costs and use.
METHODS: We analyzed Medicare fee-for-service (FFS) claims from 2017 through 2019. The sample included 41 million beneficiaries: 727,700 beneficiaries with a new dementia diagnosis in 2017. We calculated descriptive statistics and conducted generalized linear regression models by subtype of dementia.
RESULTS: Annual Medicare costs for beneficiaries with dementia ranged from $22,840 for frontotemporal dementia to $44,896 for vascular dementia compared to $9,034 for beneficiaries without dementia. Comparing beneficiaries across dementia subtypes, the greatest differences were in the use of home health and hospice care.
CONCLUSIONS: These analyses demonstrate substantial heterogeneity across dementia subtypes, which will be important in developing models of care that improve value for people with dementia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Alzheimer's & dementia : the journal of the Alzheimer's Association - 19(2023), 8 vom: 15. Aug., Seite 3295-3305 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Parasrampuria, Sonal [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 11.08.2023 Date Revised 11.08.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/alz.12953 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352598697 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM352598697 | ||
003 | DE-627 | ||
005 | 20231226054108.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/alz.12953 |2 doi | |
028 | 5 | 2 | |a pubmed24n1175.xml |
035 | |a (DE-627)NLM352598697 | ||
035 | |a (NLM)36749936 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Parasrampuria, Sonal |e verfasserin |4 aut | |
245 | 1 | 0 | |a Disaggregating the dementia monolith |b An analysis of variation in Medicare costs and use by dementia subtype |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.08.2023 | ||
500 | |a Date Revised 11.08.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 Alzheimer's Association. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. | ||
520 | |a IMPORTANCE: With an aging population, it is necessary to systematically examine variation in costs and use of Medicare services by dementia subtype. We provide the first national estimates for dementia by subtype, and the respective Medicare costs and use | ||
520 | |a METHODS: We analyzed Medicare fee-for-service (FFS) claims from 2017 through 2019. The sample included 41 million beneficiaries: 727,700 beneficiaries with a new dementia diagnosis in 2017. We calculated descriptive statistics and conducted generalized linear regression models by subtype of dementia | ||
520 | |a RESULTS: Annual Medicare costs for beneficiaries with dementia ranged from $22,840 for frontotemporal dementia to $44,896 for vascular dementia compared to $9,034 for beneficiaries without dementia. Comparing beneficiaries across dementia subtypes, the greatest differences were in the use of home health and hospice care | ||
520 | |a CONCLUSIONS: These analyses demonstrate substantial heterogeneity across dementia subtypes, which will be important in developing models of care that improve value for people with dementia | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Medicare costs | |
650 | 4 | |a dementia | |
650 | 4 | |a home health | |
650 | 4 | |a hospice | |
700 | 1 | |a Bijelic, Elvedin |e verfasserin |4 aut | |
700 | 1 | |a Bott, David M |e verfasserin |4 aut | |
700 | 1 | |a Driessen, Julia |e verfasserin |4 aut | |
700 | 1 | |a Lipp, Michael J |e verfasserin |4 aut | |
700 | 1 | |a Ling, Shari M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Alzheimer's & dementia : the journal of the Alzheimer's Association |d 2005 |g 19(2023), 8 vom: 15. Aug., Seite 3295-3305 |w (DE-627)NLM168942356 |x 1552-5279 |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2023 |g number:8 |g day:15 |g month:08 |g pages:3295-3305 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/alz.12953 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 19 |j 2023 |e 8 |b 15 |c 08 |h 3295-3305 |